Yuan-Bin Yu

1.3k total citations
38 papers, 1.0k citations indexed

About

Yuan-Bin Yu is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Yuan-Bin Yu has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Pathology and Forensic Medicine and 9 papers in Genetics. Recurrent topics in Yuan-Bin Yu's work include Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Yuan-Bin Yu is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Yuan-Bin Yu collaborates with scholars based in Taiwan, United States and South Sudan. Yuan-Bin Yu's co-authors include Jyh-Pyng Gau, Cheng‐Hwai Tzeng, Tzeon-Jye Chiou, Liang-Tsai Hsiao, Chun‐Yu Liu, Ying-Chung Hong, Denis F. Noubouossie, Tzong‐Shyuan Lee, Matthew F. Whelihan and Rafał Pawliński and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Yuan-Bin Yu

38 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuan-Bin Yu Taiwan	15	332	247	233	225	210	38	1.0k
Roberto Caporale Italy	14	255 0.8×	183 0.7×	78 0.3×	175 0.8×	272 1.3×	30	861
Conor O’Keane Ireland	17	192 0.6×	148 0.6×	123 0.5×	85 0.4×	254 1.2×	44	1.1k
Elisa Menegatti Italy	21	111 0.3×	171 0.7×	257 1.1×	164 0.7×	260 1.2×	76	1.3k
Hiroshi Osawa Japan	19	173 0.5×	125 0.5×	108 0.5×	144 0.6×	241 1.1×	120	1.2k
Rajendra Ramsamooj United States	14	205 0.6×	99 0.4×	93 0.4×	154 0.7×	256 1.2×	32	938
Padmini Malladi United States	15	474 1.4×	377 1.5×	147 0.6×	212 0.9×	354 1.7×	27	1.4k
Giancarlo Labbadia Italy	20	454 1.4×	67 0.3×	299 1.3×	253 1.1×	127 0.6×	38	1.4k
Yujin Ye China	22	128 0.4×	123 0.5×	312 1.3×	44 0.2×	412 2.0×	42	1.3k
Huiping Chen China	20	117 0.4×	84 0.3×	153 0.7×	65 0.3×	273 1.3×	56	1.2k
Kazutoshi Okabe Japan	15	247 0.7×	96 0.4×	115 0.5×	234 1.0×	85 0.4×	43	707

Countries citing papers authored by Yuan-Bin Yu

Since Specialization

Citations

This map shows the geographic impact of Yuan-Bin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan-Bin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan-Bin Yu more than expected).

Fields of papers citing papers by Yuan-Bin Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan-Bin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan-Bin Yu. The network helps show where Yuan-Bin Yu may publish in the future.

Co-authorship network of co-authors of Yuan-Bin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan-Bin Yu. A scholar is included among the top collaborators of Yuan-Bin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan-Bin Yu. Yuan-Bin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Yuan-Bin, et al.. (2025). Glucosamine induces hepatic FGF21 expression by activating the Akt/mTOR/p70S6K axis and driving PGC-1α activity. Scientific Reports. 15(1). 13096–13096. 1 indexed citations

Ko, Po‐Shen, Yuan-Bin Yu, Man‐Hsin Hung, et al.. (2017). Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib. Current Medical Research and Opinion. 33(10). 1737–1744. 8 indexed citations

Ko, Po‐Shen, Hao‐Yuan Wang, Chia‐Jen Liu, et al.. (2017). Clinical-associated characteristics and microbiological features of bloodstream nontyphoidal salmonella infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 96(9). 1533–1540. 2 indexed citations

Chen, Chien‐Ting, Chun‐Yu Liu, Yuan-Bin Yu, et al.. (2017). Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients. PLoS ONE. 12(9). e0185210–e0185210. 7 indexed citations

Hsiao, Liang-Tsai, Hao‐Yuan Wang, Tzeon-Jye Chiou, et al.. (2016). Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients. Medicine. 95(11). e3064–e3064. 9 indexed citations

Chien, Sheng‐Hsuan, Jyh-Pyng Gau, Chia‐Jen Liu, et al.. (2016). Prognostic Factors on the Graft‐versus‐Host Disease‐Free and Relapse‐Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation. Stem Cells International. 2016(1). 5143071–5143071. 14 indexed citations

Huang, Shang‐Yi, Yuan-Bin Yu, Su‐Peng Yeh, et al.. (2016). A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan. Journal of the Formosan Medical Association. 116(9). 705–710. 2 indexed citations

Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Yuan-Bin Yu, et al.. (2015). Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. Journal of the Chinese Medical Association. 78(7). 400–407. 3 indexed citations

Gau, Jyh-Pyng, Chih‐Cheng Chen, Chia‐Jen Liu, et al.. (2015). No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation. Blood Cells Molecules and Diseases. 55(1). 36–39. 5 indexed citations

10.

Lee, Tzong‐Shyuan, et al.. (2015). β Common Receptor Mediates Erythropoietin‐Conferred Protection on OxLDL‐Induced Lipid Accumulation and Inflammation in Macrophages. Mediators of Inflammation. 2015(1). 439759–439759. 17 indexed citations

11.

Wang, Hao‐Yuan, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin. Medicine. 93(27). e243–e243. 11 indexed citations

12.

Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B. Leukemia & lymphoma. 56(8). 2357–2364. 12 indexed citations

13.

Liu, Chun‐Yu, Hsueh‐Ju Lu, Man‐Hsin Hung, et al.. (2013). Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1513–1520. 15 indexed citations

14.

Hung, Man‐Hsin, Yuan-Bin Yu, Ying-Chung Hong, et al.. (2012). Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation. Annals of Hematology. 91(12). 1907–1915. 6 indexed citations

15.

Liu, Chia‐Jen, Ying-Chung Hong, Shih-Hao Liu, et al.. (2011). Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification. Leukemia & lymphoma. 53(2). 289–294. 6 indexed citations

16.

Teng, Hao‐Wei, Ying-Chung Hong, Chun‐Yu Liu, et al.. (2011). International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. Annals of Hematology. 91(1). 93–102. 5 indexed citations

17.

Liu, Chun‐Yu, Jyh-Pyng Gau, Liu H, et al.. (2011). Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes. Clinics. 66(12). 2055–2061. 15 indexed citations

18.

Liu, Chia‐Jen, Chun‐Yu Liu, Ying-Chung Hong, et al.. (2011). Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma. Annals of Hematology. 90(10). 1145–1151. 32 indexed citations

19.

Hong, Ying-Chung, Liang-Tsai Hsiao, Yuan-Bin Yu, et al.. (2010). Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. European Journal Of Haematology. 86(3). 237–245. 3 indexed citations

20.

Chen, Chih‐Cheng, Kuan‐Der Lee, Jyh-Pyng Gau, et al.. (2005). Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation. Annals of Hematology. 84(10). 675–680. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact